Company News

Stiefel To Sell PanOxyl Acne Washes OTC

Creamy washes available in May.

Author Image

By: TOM BRANNA

Editor

Stiefel will roll out two OTC versions of its “most-prescribed BPO Acne Wash formulations.” The launch will occur in the technical exhibit at the American Academy of Dermatology annual meeting in New Orleans.


Indicated for the treatment of acne, Stiefel will market two products OTC under the PanOxyl Brand.—PanOxyl Acne Creamy Wash in 4% BPO and 8% BPO. Both feature a patented delivery system including dimethyl Iiosorbide (DMI) that solubilizes BPO and greatly reduces particulate-based skin irritation and inflammation commonly experienced with conventional BPO formulations, according to the company.

“Stiefel’s Creamy Wash formulations have been physician favorites for several years,” said Shayne Sundholm, vice president, U.S. non prescription dermatology at Stiefel. “And we are excited to be able to offer them to a larger number of consumers through the retail market.”
Product will be available for shipment in May 2011.

Keep Up With Our Content. Subscribe To Happi Newsletters